Roche engagement report
@Roche - 237K followers on X
Measured over 9 original posts from a 30-day window, last computed on September 29, 2026.
Engagement
A typical post picks up 23 interactions against 237K followers, an engagement rate of 0.01%. Measured over 9 original posts, its engagement rate beats 23% of 20,444 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 3.2K times each, and 0.713% of those impressions turn into an interaction. That is about 1.36% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.3 posts a day over the last 30 days, though only 27% of days saw any activity at all. Most posts go out around 07:00 UTC, and Monday is the busiest day of the week. Of the 9 posts sampled, 100% carry an image or video and 78% link out. The account's strongest tracked post pulled 55 interactions, about 3.2x its own typical post. Recurring topics include #media, #follicularlymphoma, #hematology.
Measured over 9 original posts from a 30-day window, last computed on September 29, 2026. Recurring tags: #media, #follicularlymphoma, #hematology.
Compared with accounts its own size
Roche's engagement rate beats 23% of the tracked X accounts closest to it in follower count (20,444 accounts, accounts of similar size (decile 9 of 10)). A percentile is spread evenly by construction, so 50 really is the middle of that group and 90 really is its top tenth.
On engagement per impression rather than per follower it beats 34% of the same group. When those two numbers disagree, the gap is about how far its posts travel rather than how people react to them.
Where this sits in the catalog
At 0.01%, Roche sits above the 10th percentile of the 205,048 accounts in this comparison. That places it in the bottom 25% band, which runs below 0.024%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.004% |
| 25th percentile | 0.024% |
| 50th percentile | 0.143% |
| 75th percentile | 0.678% |
| 90th percentile | 2.55% |
| 99th percentile | 82.4% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 07:00 UTC, and Monday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 89K |
| 01:00 UTC | -2% | 90K |
| 02:00 UTC | -3% | 88K |
| 03:00 UTC | -4% | 94K |
| 04:00 UTC | -5% | 76K |
| 05:00 UTC | -4% | 75K |
| 06:00 UTC | -5% | 86K |
| 07:00 UTC | -5% | 93K |
| 08:00 UTC | -4% | 108K |
| 09:00 UTC | -4% | 124K |
| 10:00 UTC | -3% | 129K |
| 11:00 UTC | -3% | 141K |
| 12:00 UTC | -3% | 154K |
| 13:00 UTC | -3% | 167K |
| 14:00 UTC | -4% | 173K |
| 15:00 UTC | -2% | 176K |
| 16:00 UTC | -3% | 171K |
| 17:00 UTC | -3% | 159K |
| 18:00 UTC | -2% | 149K |
| 19:00 UTC | -2% | 141K |
| 20:00 UTC | -1% | 131K |
| 21:00 UTC | 0% | 116K |
| 22:00 UTC | -2% | 100K |
| 23:00 UTC | -1% | 90K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 393K |
| Monday | +1% | 483K |
| Tuesday | -2% | 520K |
| Wednesday | -3% | 472K |
| Thursday | -2% | 430K |
| Friday | -3% | 447K |
| Saturday | +2% | 393K |
Formats this account uses
Its own posting mix on the left, and what each of those formats does across every account we track on the right. Only formats where the effect clears our publish test appear here, so an empty row is a format we could not measure rather than one that does nothing.
| Format | This account | Catalog effect | 95% interval | Accounts behind it |
|---|---|---|---|---|
| Image or video | 100% of posts | +111% | +108% to +115% | 34K |
| Outbound link | 78% of posts | -41% | -42% to -40% | 32K |
| Typical length | - | +15% | +14% to +16% | 32K |
- 100% of this account's sampled posts carry an image or video. Across the catalog, posts with an image or video run 111% above the same accounts' other posts.
- 78% of its posts carry a link off X. Across the catalog, posts with an outbound link run 41% below the same accounts' other posts, so a large share of this account's output sits in the weakest bucket we measure.
- Its average post runs 314 characters, which falls in the over 280 characters band. Across the catalog, posts over 280 characters run 15% above the same accounts' other posts.
These are catalog-wide differences applied to this account's own posting mix, not a measurement of how each format performs for this account specifically. We keep one median per account, not one per format per account, so the second thing is not something this data can tell you.
Best tweets
- Dec 12, 20253.2x their median
The future of faster drug discovery may be on the horizon. #Organoids, tiny simplified versions of human tissues, help us test potential medicines in faster, more predictive ways. A new review with @Hubrecht Institute explores how. 👏 Thank you to the scientists driving this work. Read more 👉 https://t.co/DBPM8LMB7Y #DrugDiscovery #Innovation #pRED @IHB_Research @Hans Clevers
- Apr 21, 20261.5x their median
#MEDIA – We are pleased to announce that the US FDA has accepted Roche’s New Drug Application in #SystemicLupusErythematos. This important step moves us closer to providing a first-of-its-kind targeted treatment for people whose lives are significantly impacted by this debilitating autoimmune disease. https://t.co/4YjnGnVrcy $ROG $RHHBY
- Sep 14, 2026
#MEDIA – We’re pleased to share positive Phase III data from our collaborator MediLink’s study in Chinese patients with relapsed small-cell #LungCancer, being presented at #WCLC26. Read more here: https://t.co/hTWX0ZFV0o $ROG $RHHBY https://t.co/NynhjHIRKG
- Apr 24, 2026
We’re proud to announce our continued collaboration with the @wfhemophilia, through their Humanitarian Aid Program, working together to expand access to care for people with #haemophilia in locations where there is little to no access to treatment. Read more via their website: https://t.co/Sg6jKEivRS #BleedingDisorders #PublicHealth #WFHCongress2026
- Jul 20, 2026
Roche’s sequencing by expansion (SBX) technology is transforming DNA sequencing! By converting nucleotide bases into long molecules before it passes through microscopic pores, it scales up molecular signals into digital data.✨ #Biotech #Innovation https://t.co/J3icV5bBJr (Roche's sequencing technology is currently for research use only.)
- Apr 22, 2026
#MEDIA - We’re pleased to share detailed, late-breaking results at #AANAM from two positive Phase III studies of our investigational oral, brain-penetrant medicine in relapsing multiple sclerosis. https://t.co/yQC1GJva21 $RHHBY $ROP https://t.co/MsdCxA6sw2
- Feb 8, 2026
MEDIA - We’re pleased to share new Phase III data at #ACTRIMSForum for our investigational medicine in primary progressive multiple sclerosis. 👉https://t.co/xFTCoZxbOZ $RHHBY $ROG https://t.co/Ag4FE22W4v
- Dec 22, 20251.7x their median
#MEDIA – We are pleased to announce that the US FDA has approved our bispecific antibody for subcutaneous administration, for people with relapsed or refractory #lymphoma, reducing administration time from 2-4 hours to approximately one minute. https://t.co/VBgp33bJO2 $RHHBY $ROG https://t.co/WFOh4YbtoC
- Apr 23, 2026
Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc. For more details, click here ➡️ https://t.co/fMbDs05AyR $ROG $RHHBY #FinancialResults https://t.co/PVsKyiP61t
- Mar 23, 2026
Strategic vision requires world-class infrastructure and implementation. We are proud to announce the inauguration of Building 92 in Basel—a pivotal milestone in Roche’s R&D evolution. As the new headquarters for @IHB_Research, B92 is more than a building; it is home to a multidisciplinary engine where we turn the potential of Human Model Systems into industry reality. Find out more 👉 https://t.co/InjQACMHws
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell Twitter (X) accounts - escrow-protected
PlayerSells is an escrow marketplace for Twitter (X) accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 23 interactions against 237K followers, an engagement rate of 0.01%. Measured over 9 original posts, its engagement rate beats 23% of 20,444 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 3.2K times each, and 0.713% of those impressions turn into an interaction. That is about 1.36% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 0.3 posts a day over the last 30 days, though only 27% of days saw any activity at all. Most posts go out around 07:00 UTC, and Monday is the busiest day of the week. Of the 9 posts sampled, 100% carry an image or video and 78% link out. The account's strongest tracked post pulled 55 interactions, about 3.2x its own typical post. Recurring topics include #media, #follicularlymphoma, #hematology.
- What is Roche's engagement rate on X?
- Roche (@Roche) has an engagement rate of 0.01%, based on the median interactions across 9 original posts from the last 30 days against 237,135 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.01%, Roche sits above the 10th percentile of the 205,048 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @Roche have real engagement?
- Its engagement rate beats 23% of the tracked X accounts closest to it in follower count (20,444 accounts), which puts it in the bottom quarter for its size group. Ranking inside a size band matters because engagement rate falls as accounts grow, so a raw rate would mostly re-measure the follower count. It is a starting point for a look at follower quality, not a verdict on it.
- When does @Roche post?
- Most posts go out around 07:00 UTC, and Monday is its busiest day, at roughly 0.3 posts per day across the measured window.